Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
---|---|---|---|---|---|---|---|
Ganciclovir | 0.90 | No resistance | Recombinant | Details | Phenotypic evaluation of previously uncharacterized cytomegalovirus DNA polymerase sequence variants detected in a valganciclovir treatment trial. (Apr 2014) | ||
Cidofovir | 0.90 | No resistance | Recombinant | Details | Phenotypic evaluation of previously uncharacterized cytomegalovirus DNA polymerase sequence variants detected in a valganciclovir treatment trial. (Apr 2014) | ||
Foscarnet | 1.10 | No resistance | Recombinant | Details | Phenotypic evaluation of previously uncharacterized cytomegalovirus DNA polymerase sequence variants detected in a valganciclovir treatment trial. (Apr 2014) |
Mutant | Resistances |
---|---|
Q795R |
Ganciclovir:
|
Q795R |
Cidofovir:
|
Q795R |
Foscarnet:
|